Ra Capital Management +3 more
10% owner
Common Stock
Excluded from the common-share buying signal. See trade details.
- Reported value
- $525.02K
- Reported price
- $7.04 / share
Adicet Bio, Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
10% owner
Common Stock
Excluded from the common-share buying signal. See trade details.
10% owner
Common Stock
Excluded from the common-share buying signal. See trade details.
10% owner
Common Stock
Excluded from the common-share buying signal. See trade details.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| +310% owner | Common StockPurchaseExcluded from purchase score | 74,577$7.04 / share | $525.02K | Feb 18Filed Apr 13 · 54d later | SEC filing |
| +310% owner | Common StockPurchaseExcluded from purchase score | 74,268$7.21 / share | $535.47K | Feb 19Filed Apr 13 · 53d later | SEC filing |
| +310% owner | Common StockPurchaseExcluded from purchase score | 74,751$7.27 / share | $543.44K | Feb 20Filed Apr 13 · 52d later | SEC filing |
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
This reflects the filings imported so far, not a complete trading history.